Concord Drugs Share Price
09 Nov, 2026 4:01 PM (IST)
Concord Drugs Performance
- Today's Low
- ₹71
- Today's High
- ₹75
- 52 Week Low
- ₹60
- 52 Week High
- ₹93
- Open Price₹75
- Previous Close₹72
- Volume6,152
- 50 DMA₹71.70
- 100 DMA₹73.40
- 200 DMA₹73.20
Concord Drugs Chart
Investment Returns
- Over 1 Month + 6.14%
- Over 3 Month + 4.93%
- Over 6 Month -8.33%
- Over 1 Year + 5.7%
Smart Investing Starts Here Start SIP with Concord Drugs for Steady Growth!
Concord Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 48
- PEG Ratio
- 0.1
- Market Cap Cr
- 98
- P/B Ratio
- 2
- Average True Range
- 4.6
- EPS
- 1.6
- Dividend Yield
- 0
- MACD Signal
- -0.6
- RSI
- 56.84
- MFI
- 43.79
Latest Stock News Updates
Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve Results for Quarter ending Sep 30, 2026.
- BSE India
- 5 days 6 hours ago
Annual general meeting -Scrutinizer''s Report
- BSE India
- 1 month 1 week ago
Summary Proceedings of AGM
- BSE India
- 1 month 1 week ago
Concord Drugs Financials
Concord Drugs Technicals
EMA & SMA
- Bearish Moving Average 2
- Bullish Moving Average 14
- 20 Day
- ₹69.60
- 50 Day
- ₹71.70
- 100 Day
- ₹73.40
- 200 Day
- ₹73.20
Resistance and Support
- R3 78.70
- R2 77.00
- R1 74.80
- S1 70.90
- S2 69.20
- S3 67.00
Concord Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-11-12 | Quarterly Results | |
| 2026-08-10 | Quarterly Results | |
| 2026-05-27 | Audited Results | |
| 2026-02-14 | Quarterly Results | |
| 2025-11-13 | Quarterly Results |
About Concord Drugs
Concord Drugs are prepared with generally accepted accounting principles in India under the historical cost convention and on an accrual basis of accounting. View More- NSE Symbol
- CONCORD
- BSE Symbol
- 538965
- ISIN
- INE858L01010
Similar Stocks to Concord Drugs
Popular Stocks
Concord Drugs FAQs
Concord Drugs share price is ₹74 As on 11 November, 2026 | 00:27
The Market Cap of Concord Drugs is ₹98.4 Cr As on 11 November, 2026 | 00:27
The P/E ratio of Concord Drugs is 48 As on 11 November, 2026 | 00:27
The PB ratio of Concord Drugs is 2 As on 11 November, 2026 | 00:27
The 52 week High & Low of Concord Drugs is ₹92.5/₹60 respectively As on 11 November, 2026 | 00:27
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.